Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) announced that the company and its subsidiary Taizhou Fudan-Zhangjiang Pharmaceutical Co. Ltd. (hereinafter referred to as...)
According to the report from Zhitong Finance APP, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) announced that the company and its subsidiary Taizhou Fudan-Zhangjiang Pharmaceutical Co. Ltd. (hereinafter referred to as "Taizhou Fudan-Zhangjiang") and Shanghai Origin Biotechnology Co., Ltd. have cumulatively received government subsidies amounting to 31.1363 million yuan from the beginning of the year to the date of this announcement. This amount includes the government subsidies received by the subsidiary Taizhou Fudan-Zhangjiang from the beginning of the year to June 18, 2024, totaling 16.2 million yuan.